Purchase
Description
ENTYVIO (vedolizumab), an integrin receptor antagonist, is a humanized IgG1 monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.
Vedolizumab is supplied at a concentration of 60 mg/mL as a sterile, preservative-free, clear to slightly opalescent, colorless to pale-yellow solution of pH 6.3, which contains 4.6 mg/mL L-histidine, 4.28 mg/mL L-histidine monohydrochloride, 26.34 mg/mL L-arginine hydrochloride, 100 mg/mL sucrose and 0.6 mg/mL polysorbate 80.
Properties
|
Name
|
Vedolizumab
|
|
CAS
NO.
|
943609-66-3
|
|
Type
|
Whole
antibody
|
|
Source
|
Humanized
|
|
Target
|
Integrin α4β7
|
|
Clone
|
Monoclone
|
|
Molecular
Weight
|
147 kDa
|
|
Formula
|
C6528H10072N1732O2042S42
|
|
Antibody
Form
|
Purified immunoglobulin
|
|
Physical
Form
|
Solution
|
|
Grade
Standard
|
Medicine Grade
|
|
Place
of Origin
|
China (Mainland)
|
|
Storage
|
-70±15℃ for long-term
storage, 2-8℃ for short-term storage, away from light.
|
Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis
/en/UploadFile/file/201805/20180508155364056405.rar
Detail information about the product please refer the website below：
https://en.wikipedia.org/wiki/Vedolizumab
|
